The Gerstner Family Foundation supports basic and translational biomedical research, access to an excellent education for young people in grades K-12, and organizations that assist people who have suffered temporary setbacks and need a “helping hand” to restore their equilibrium.


  • ‘Liquid biopsy’ can help predict outcomes in metastatic triple-negative breast cancer
    March 6, 2018

    A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC). Although TNBC represents just 10-15 percent of all breast cancer diagnoses, the disease is responsible for 35 percent of all breast cancer-related deaths. While significant advances in understanding the genomic drivers of primary TNBC have been made in the past decade, relatively little is known about metastatic disease because surgical tumor biopsies are rarely obtained from these patients. Funding for the study was provided by the Gerstner Family Foundation, Susan G. Komen for the Cure, The Pink Agenda, Breast Cancer Research Foundation, V Foundation for Cancer Research and National Cancer Institute.

View More News

About Us

The Gerstner Family Foundation was founded in 1989 by Louis V. Gerstner, Jr. and his family. The foundation is an expression of Mr. Gerstner’s strong personal commitment to give back to society, which he considers as important a part of his legacy as his exceptional career in business. Most of the foundation’s giving is in New York City, Boston and Palm Beach and their surrounding communities.

Learn More